Myopia management CPD lecture

Professor James Wolffsohn

Dispensing opticians and optometrists attending 100% Optical in London this coming weekend (28 February to 2 March) are invited to attend a CPD lecture examining the growing evidence base for contrast management as a mechanism to slow myopia progression.

Professor James Wolffsohn, head of optometry at Aston University and chief clinical scientist for the International Myopia Institute, will present ‘Managing contrast to slow myopia progression’ on Saturday 28 February from 12-1pm.

Widely recognised for his contributions to optometric research and education, Professor Wolffsohn will present insights that shed new light on long-held assumptions about the visual signals that influence eye growth, and explain how these findings contribute to the scientific basis for DOT spectacle lenses, which provide myopia control through contrast management.

DOT lenses are the first myopia management treatment specifically designed to reduce retinal contrast signalling through the incorporation of light scattering elements¹. The lenses have been shown to reduce myopia progression by up to 75 per cent after 12 months of wear across diverse populations^1,2*, and are effective for children as young as six^2,3.

The presentation will address three key questions currently shaping clinical discussion in myopia management: what is the evidence base for contrast management in myopia treatment; how does contrast management relate to defocus-based interventions; and what is the clinical relevance for everyday optometric practice.

Find out more about this session on the 100% Optical website.

References

1. Rappon et al. Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). Br. J. Ophthalmol. 2023;107(11):1709-1715.
2. Laughton et al. Control of myopia using contrast modulation spectacle lenses in a Chinese population: 12-month results. Invest. Ophthalmol. Vis. Sci. 2025;66(8):2815.
3. Laughton et al. Two-year effectiveness of a novel myopia management spectacle lens in young myopes. NCC 2022 conference presentation.
*Patient population aged six to 10 years (CYPRESS) and six to 13 years (CATHAY). Prescribed DOT lens wear time was 10 hours per day.